Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid diseaseLivius Penter, Catherine J. Wu, Yang Liu et al.|Blood|2023Cited by 51
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Catherine J. Wu, Yi Zhang et al.|Blood|2021Cited by 42
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)Helen X. Chen, Magdalena Thurin, Xiaole Shirley Liu et al.|Clinical Cancer Research|2021Cited by 31
Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDSLivius Penter, Catherine J. Wu, Yang Liu et al.|Blood|2022Cited by 2